P3.02a-005 The Association between the Percentage of Anaplastic Lymphoma Kinase(ALK)-Positive Cells and Efficacy of ALK Inhibitor

Authors :: Hidetoshi Hayashi
Toshihiko Kaneda
Masayuki Takeda
Tae Tanaka
Hiroyasu Kaneda
Toshihide Yokoyama
Hiroshige Yoshioka
Tadashi Ishida
Koji Haratani
Kazuhiko Nakagawa
Kunio Okamoto
Source :: Journal of Thoracic Oncology. 12:S1162
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Pulmonary and Respiratory Medicine
ALK inhibitor
Oncology
medicine.drug_class
business.industry
medicine
Cancer research
ALK-Positive
Anaplastic lymphoma kinase
business

Tools